Scully M, Cataland SR, Peyvandi F, et al. Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura. ASH 59th Annual Meeting & Exhibition, abstract LBA-1.
Profylactisch itacitinib verlaagt incidentie cytokine release syndroom na immuun-effectorceltherapie
mei 2025 | Lymfoom